Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Brain Research|October 24, 2013
Ghrelin but not nesfatin-1 affects certain forms of learning and memory in both rats and miceQianqian Zhu, Kewei Xiao, Ming Yu, et al.
Neurology and Therapy|December 4, 2025
AXIN1 Polymorphisms Potentially Modulate Parkinson's Disease Susceptibility: A Cross-Sectional Study in Northern Han Chinese and White PopulationsZhen Kong, Ran Yu, Chengqian Li, et al.
Frontiers in Endocrinology|August 1, 2024
Clinicopathological features affecting the efficacy in 131I ablation therapy of papillary thyroid carcinoma with lymph node metastasisXiang Xu, Chengqian Li, Xiaolong Yu, et al.
Journal of Cellular and Molecular Medicine|June 4, 2021
Mutation of the novel acetylation site at K414R of BECN1 is involved in adipocyte differentiation and lipolysisChengqian Li, Jun Xu, Qing Yu, et al.
Frontiers in Pharmacology|September 6, 2024
Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trialPingping Lin, Chengqian Li, Yanping Liu, et al.
Endocrine Journal|July 21, 2012
Long term effects of the implantation of autologous bone marrow mononuclear cells for type 2 diabetes mellitusJianxia Hu, Chengqian Li, Li Wang, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 1, 2021
Measurement of talc in flour by the prompt-gamma ray neutron activation analysis methodXu Xu, Jingbin Lu, Yi Chang, et al.
Journal of Clinical Pharmacology|September 22, 2022
A Drug-Drug Interaction Study of a Novel Selective Urate Reabsorption Inhibitor, SHR4640, and Xanthine Oxidase Inhibitor, Febuxostat, in Patients With Primary HyperuricemiaChenjing Wang, Qing Yu, Xin Jiang, et al.
Diabetes, Obesity & Metabolism|June 25, 2025
Efficacy and safety of PEGylated uricase in healthy adults and patients with hyperuricaemia: A phase I, randomized, double-blind, dose-escalation, placebo-controlled trialFeifei Sun, Jiahui Zhang, Zhonghai Yan, et al.
Cell Reports. Medicine|June 19, 2026
Safety and efficacy of GZR18, a long-acting GLP-1 analog, in Chinese patients with type 2 diabetes: A randomized, double-blind, phase 1b/2a trialMing Liu, Xuhong Wang, Meizi Li, et al.
Pageof 6